Concepedia

Andrew Conroy

AC

Statistics

Publications

3

Citations

476

H-Index

3

Active since

2009

Affiliations

University of California, San Francisco(Current)

Sunesis (United States)

Andrew Conroy is an author at University of California, San Francisco specializing in oncology, pharmacology, and protein kinase inhibitors.

Publications per year

2009–2023

3

Publications

3

Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy

Cristina Puig-Saus, Barbara Sennino, Songming Peng et al. · Nature · 2023 · 202 citations · Full text

, , +14

Voreloxin Is an Anticancer Quinolone Derivative that Intercalates DNA and Poisons Topoisomerase II

Rachael E. Hawtin, David E. Stockett, Jo Ann W. Byl et al. · PLoS ONE · 2010 · 149 citations · Full text

, , +14

SNS-032 is a potent and selective CDK 2, 7 and 9 inhibitor that drives target modulation in patient samples

Andrew Conroy, David E. Stockett, Duncan Walker et al. · Cancer Chemotherapy and Pharmacology · 2009 · 125 citations · Full text

, , +6

1–3 of 3